Rbf Capital, LLC Vascular Biogenics Ltd. Transaction History

Rbf Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.16 - $1.53 $161,146 - $212,546	-138,919 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$0.94 - $1.75 $211,316 - $393,408	-224,805 Reduced 61.81%	138,919 $211,000
Q4 2018 Feb 14, 2019	BUY	$0.6 - $1.72 $218,234 - $625,605	363,724 New	363,724 $353,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.